Changyi Quan

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Immune Response

Radical Prostatectomy

Transcription Factor

Prostate Cancer

Top Venues

Cell death & disease

Cancer reports (Hoboken, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)
Haotian Wei, Zhaochen Li, Yang Zhao, Shimiao Zhu, Simeng Wen, Changyi Quan
Six-transmembrane epithelial antigen of prostate 3 (STEAP3) is a potential prognostic biomarker in clear cell renal cell carcinoma that correlates with M2 macrophage infiltration and epithelial-mesenchymal. Cancer reports (Hoboken, N.J.) (2023)
Shimiao Zhu, Zhao Yang, Zheng Zhang, Hongli Zhang, Songyang Li, Tao Wu, Xuanrong Chen, Jianing Guo, Aixiang Wang, Hao Tian, Jianpeng Yu, Changwen Zhang, Lei Su, Zhiqun Shang, Changyi Quan, Yuanjie Niu
HOXB3 drives WNT-activation associated progression in castration-resistant prostate cancer. Cell death & disease 14 (3) (2023)